Lutz Peter M.
- Country
- Germany
- Department
- Universitätsklinik und Poliklinik für Innere Medizin IV
Research Overview
- Phase 3 Evaluation of Venetoclax and Azacitidine Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients
- Phase 3 Multicenter Open-label Randomized Study of Gilteritinib, Gilteritinib Plus Azacitidine, and Azacitidine in Newly Diagnosed FLT3-Mutated AML
- Evaluation of Apraglutide Efficacy and Safety in Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: A Randomized, Single-Blind Trial
Data & Insights
Has run more than one trial at 104 of 172 partner sites.
Specializations
Hematologic Malignancies
Specializes in treating multiple myeloma and acute myeloid leukemia, with particular focus on cases involving FLT3 mutations. Conducts research into novel therapeutic approaches for myelodysplastic neoplasia and related conditions.
- Advanced Multiple Myeloma Management
- FLT3-Mutated AML Treatment
- Myelodysplastic Disorders
Implements innovative treatment strategies for patients who have progressed after first-line therapies.
Transplant Medicine
Focuses on allogeneic stem cell transplantation procedures and post-transplant care. Specializes in developing maintenance therapies following transplantation and optimizing conditioning treatments.
- Stem Cell Transplantation Techniques
- Post-Transplant Maintenance Therapy
- Conditioning Protocol Development
Advances therapeutic approaches in transplant medicine with emphasis on long-term patient outcomes.
Graft-versus-Host Disease
Expert in treating both acute and chronic graft-versus-host disease. Investigates novel therapeutic combinations including corticosteroid-based treatments and innovative biological agents.
- Acute GVHD Management
- Chronic GVHD Interventions
- Steroid-Refractory GVHD Treatment
Develops targeted approaches for gastrointestinal manifestations of GVHD.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.